Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock Series A	Preferred Stock Series B	Preferred Stock Series C	Preferred Stock Series D	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance, beginning at Dec. 31, 2017					$ 420	$ 1,939,832	$ (3,596,408)	$ (1,656,156)
Balance, beginning (shares) at Dec. 31, 2017	80,000	14	12		651,796
Pre-merger issuances and conversions of shares
Pre-merger issuances and conversions of shares (shares)	(80,000)	(6)	(12)		3,548,204
Sale of Series C preferred stock						250,000		250,000
Sale of Series C preferred stock (Shares)			250
Founder stock returned to company					$ (75)	75
Founder stock returned to company (Shares)					(75,000)
Shares repurchased from shareholder					$ (140)	(210,503)		(210,643)
Shares repurchased from shareholder (Shares)					(139,567)
Conversion of Series B and C preferred stock			$ (2)		$ 1,616	(1,614)
Conversion of Series B and C preferred stock (Shares)		(8)	(2,467)		1,616,470
Exercise of options					$ 56	(56)
Exercise of options (Shares)					55,801
Issuance of common stock for consulting services					$ 185	400,415		400,600
Issuance of common stock for consulting services (Shares)					185,000
AgEagle debt conversion into common stock					$ 788	1,503,015		1,503,803
AgEagle debt conversion into common stock (Shares)					787,891
AgEagle shareholder common stock conversion to Enerjex common shares			$ 2		$ 6,537	(6,539)
AgEagle shareholder common stock conversion to Enerjex common shares (Shares)			2,056		2,757,063
Acquisition of Agribotix					$ 1,275	2,998,725		3,000,000
Acquisition of Agribotix (Shares)					1,275,000
Issuance of common and preferred stock for Enerjex shareholders upon merger					$ 1,887	(762,662)		(760,775)
Issuance of common and preferred stock for Enerjex shareholders upon merger (Share)	0	0	197	0	1,886,736
Issuance of Series C common stock in connection with merger, net of fees	$ 0	$ 0	$ 5	$ 0	$ 0	3,979,995		3,980,000
Issuance of Series C common stock in connection with merger, net of fees (Shares)	0	0	4,626	0	0
Issuance of Series D preferred stock and warrants for cash				$ 2		1,969,998		1,970,000
Issuance of Series D preferred stock and warrants for cash (Shares)				2,000
Share compensation period costs						110,593		110,593
Net loss							(2,079,683)	(2,079,683)
Balance, ending at Dec. 31, 2018			$ 5	$ 2	$ 12,549	12,171,274	(5,676,091)	6,507,739
Balance, ending (shares) at Dec. 31, 2018			4,662	2,000	12,549,394
Shares repurchased from shareholder								0
Conversion of Series C Preferred Stock			$ (1)		$ 2,150	(2,149)
Conversion of Series C Preferred Stock (Shares)			(1,161)		2,150,000
Acquisition of Agribotix					$ 175	(175)
Acquisition of Agribotix (Shares)					175,000
Issuance of common stock for consulting services					$ 550	189,950		190,500
Issuance of common stock for consulting services (Shares)					550,000
Dividend on Series D Preferred Stock						(162,222)		(162,222)
Share compensation period costs						260,311		260,311
Net loss							(2,522,694)	(2,522,694)
Balance, ending at Dec. 31, 2019			$ 4	$ 2	$ 15,424	$ 12,456,989	$ (8,198,785)	$ 4,273,634
Balance, ending (shares) at Dec. 31, 2019			3,501	2,000	15,424,394